Stock Information
Avalo Therapeutics Inc (AVTX)
Ticker Symbol: AVTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,010.84 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -4.75
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -58.03%
Latest News
-
Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress
Wed, Sep 23, 2026 11:00 AM
-
Avalo Therapeutics To Present Abdakibart Data At EADV Congress 2026
Wed, Sep 23, 2026 7:07 AM
Key Financials
Financial data not available